GOODRX, INC.

Lobbying for GOODRX, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $310,000.00 expenses · posted Oct 20, 2025

Lobbying activity 2

Consumer Issues/Safety/Products

Monitoring federal legislation and outreach to congressional offices.

Health Issues

-Issues regarding prescription drug pricing. -Issues regarding telehealth.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.